% | $
Quotes you view appear here for quick access.

Array BioPharma Inc. Message Board

  • buyoutmoney175 buyoutmoney175 Oct 31, 2013 12:41 AM Flag

    Read this before earnings

    Generic competition has been adversely impacting AstraZeneca’s (AZN) revenues over the past few quarters. This has put significant pressure on the company. The company is working on bolstering its pipeline. It is also looking at suitable acquisitions and deals.

5.83-0.12(-2.02%)10:38 AMEDT